These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36674402)

  • 1. I Don't Believe a Person Has to Die When Trying to Get High: Overdose Prevention and Response Strategies in Rural Illinois.
    Walters SM; Felsher M; Frank D; Jaiswal J; Townsend T; Muncan B; Bennett AS; Friedman SR; Jenkins W; Pho MT; Fletcher S; Ompad DC
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "I don't want to die": a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies.
    Abadie R
    Harm Reduct J; 2023 Jun; 20(1):75. PubMed ID: 37316884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overdose Experiences among People Who Inject Drugs in West Virginia: Personal Loss, Psychological Distress, Naloxone, and Fentanyl.
    Schneider KE; Allen ST; Winiker AK; White RH; O'Rourke A; Sherman SG; Grieb SM
    Subst Use Misuse; 2023; 58(1):22-26. PubMed ID: 36371695
    [No Abstract]   [Full Text] [Related]  

  • 4. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.
    Rivera AV; Nolan ML; Paone D; Carrillo SA; Braunstein SL
    Subst Abus; 2022; 43(1):1172-1179. PubMed ID: 35617642
    [No Abstract]   [Full Text] [Related]  

  • 5. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl overdose concerns among people who inject drugs: The role of sex, racial minority status, and overdose prevention efforts.
    Jones AA; Schneider KE; Mahlobo CT; Maggs JL; Dayton L; Tobin KE; Latkin CA
    Psychol Addict Behav; 2023 Mar; 37(2):191-198. PubMed ID: 35511529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
    Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
    Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
    [No Abstract]   [Full Text] [Related]  

  • 8. Perspectives on Fentanyl Test Strip Use among People Who Inject Drugs in Rural Appalachia.
    Allen ST; O'Rourke A; White RH; Sherman SG; Grieb SM
    Subst Use Misuse; 2020; 55(10):1594-1600. PubMed ID: 32336188
    [No Abstract]   [Full Text] [Related]  

  • 9. Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals.
    Mistler CB; Chandra DK; Copenhaver MM; Wickersham JA; Shrestha R
    J Community Health; 2021 Apr; 46(2):349-357. PubMed ID: 32997253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
    Erath TG; LaCroix R; O'Keefe E; Higgins ST; Rawson RA
    Harm Reduct J; 2024 Apr; 21(1):76. PubMed ID: 38580997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
    Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting.
    Hayashi K; Wood E; Dong H; Buxton JA; Fairbairn N; DeBeck K; Milloy MJ; Kerr T
    Drug Alcohol Rev; 2021 Sep; 40(6):964-973. PubMed ID: 33604968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urban, individuals of color are impacted by fentanyl-contaminated heroin.
    Rhodes B; Costenbader B; Wilson L; Hershow R; Carroll J; Zule W; Golin C; Brinkley-Rubinstein L
    Int J Drug Policy; 2019 Nov; 73():1-6. PubMed ID: 31330274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply.
    Bell A; Bennett AS; Jones TS; Doe-Simkins M; Williams LD
    Subst Abus; 2019; 40(1):52-55. PubMed ID: 29558283
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial.
    Jacka BP; Goldman JE; Yedinak JL; Bernstein E; Hadland SE; Buxton JA; Sherman SG; Biello KB; Marshall BDL
    Trials; 2020 Nov; 21(1):976. PubMed ID: 33243291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
    Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding intentionality of fentanyl use and drug overdose risk: Findings from a mixed methods study of people who inject drugs in New York City.
    McKnight C; Weng CA; Reynoso M; Kimball S; Thompson LM; Jarlais DD
    Int J Drug Policy; 2023 Aug; 118():104063. PubMed ID: 37270373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
    Fairbairn N; Coffin PO; Walley AY
    Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada.
    Mayer S; Boyd J; Collins A; Kennedy MC; Fairbairn N; McNeil R
    Drug Alcohol Depend; 2018 Dec; 193():69-74. PubMed ID: 30343236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.